Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.

Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K.

Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9.

2.

Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.

Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A, Garg AX.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):95-104. doi: 10.2215/CJN.05990616. Epub 2016 Dec 29.

PMID:
28034851
3.

Optimal breast cancer screening strategies for older women: current perspectives.

Braithwaite D, Demb J, Henderson LM.

Clin Interv Aging. 2016 Feb 3;11:111-25. doi: 10.2147/CIA.S65304. eCollection 2016. Review.

4.

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.

Zeidan B, Jackson TR, Larkin SE, Cutress RI, Coulton GR, Ashton-Key M, Murray N, Packham G, Gorgoulis V, Garbis SD, Townsend PA.

Oncotarget. 2015 Aug 28;6(25):21421-7.

5.

Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.

Calip GS, Law EH, Ko NY.

Breast Cancer Res Treat. 2015 Jun;151(3):687-96. doi: 10.1007/s10549-015-3439-7. Epub 2015 May 27.

6.

Effects of age on the detection and management of breast cancer.

McGuire A, Brown JA, Malone C, McLaughlin R, Kerin MJ.

Cancers (Basel). 2015 May 22;7(2):908-29. doi: 10.3390/cancers7020815. Review.

8.

Breast cancer screening: an evidence-based update.

Fuller MS, Lee CI, Elmore JG.

Med Clin North Am. 2015 May;99(3):451-68. doi: 10.1016/j.mcna.2015.01.002. Epub 2015 Mar 5. Review.

9.

Overdiagnosis: epidemiologic concepts and estimation.

Bae JM.

Epidemiol Health. 2015 Feb 10;37:e2015004. doi: 10.4178/epih/e2015004. eCollection 2015.

10.

Setting a health policy research agenda for controlling cancer burden in Korea.

Jang SI, Cho KH, Kim SJ, Lee KS, Park EC.

Cancer Res Treat. 2015 Apr;47(2):149-57. doi: 10.4143/crt.2013.167. Epub 2014 Sep 11.

11.

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.

Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, D Schnall M, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF.

Cancer. 2014 Oct 1;120(19):2955-64. doi: 10.1002/cncr.28771. Epub 2014 May 15. Review.

12.

Statistical illiteracy in residents: what they do not learn today will hurt their patients tomorrow.

Wegwarth O.

J Grad Med Educ. 2013 Jun;5(2):340-1. doi: 10.4300/JGME-D-13-00084.1. No abstract available.

13.

Patterns and determinants of breast and cervical cancer non-screening among Appalachian women.

Schoenberg NE, Studts CR, Hatcher-Keller J, Buelt E, Adams E.

Women Health. 2013;53(6):552-71. doi: 10.1080/03630242.2013.809400.

14.

Citations of scientific results and conflicts of interest: the case of mammography screening.

Rasmussen K, Jørgensen KJ, Gøtzsche PC.

Evid Based Med. 2013 Jun;18(3):83-9. doi: 10.1136/eb-2012-101216. Epub 2013 May 1.

15.

Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study.

Waller J, Douglas E, Whitaker KL, Wardle J.

BMJ Open. 2013 Apr 22;3(4). pii: e002703. doi: 10.1136/bmjopen-2013-002703. Print 2013.

16.

Number needed to sacrifice: statistical taboo or decision-making tool?

Trewby P.

JRSM Short Rep. 2013 Mar;4(3):22. doi: 10.1177/2042533313476684. Epub 2013 Mar 6.

17.

Global breast cancer: the lessons to bring home.

Formenti SC, Arslan AA, Love SM.

Int J Breast Cancer. 2012;2012:249501. doi: 10.1155/2012/249501. Epub 2011 Dec 5.

18.

Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.

Chay WY, Ong WS, Tan PH, Jie Leo NQ, Ho GH, Wong CS, Chia KS, Chow KY, Tan M Sr, Ang P Sr.

Breast Cancer Res. 2012 Jan 30;14(1):R19.

19.

Potential contribution of aspirin to cancer control programmes.

Morgan G.

Ecancermedicalscience. 2008;2:100. doi: 10.3332/ecancer.2008.100. Epub 2008 Nov 12.

20.

Early detection in head and neck cancer - current state and future perspectives.

Gerstner AO.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008;7:Doc06. Epub 2010 Oct 7.

Supplemental Content

Support Center